Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 133,791 | 141,919 | 440,006 | 133,093 | 125,750 |
| Cost of Goods | 4,745 | 4,170 | 2,227 | 3,079 | 2,958 |
| Gross Profit | 129,046 | 137,749 | 437,779 | 130,014 | 122,792 |
| Operating Expenses | 215,305 | 195,423 | 217,403 | 215,942 | 196,719 |
| Operating Income | -85,514 | -57,504 | 220,603 | -85,849 | -72,969 |
| Interest Expense | 2,130 | 2,122 | 2,238 | 2,340 | 2,357 |
| Other Income | -15,231 | -4,445 | 6,547 | 4,416 | -5,222 |
| Pre-tax Income | -102,875 | -64,071 | 224,912 | -83,773 | -80,548 |
| Income Tax | 2,260 | 1,094 | 299 | -1,307 | 327 |
| Net Income Continuous | -105,135 | -65,165 | 224,613 | -82,466 | -80,875 |
| Net Income | $-105,135 | $-65,165 | $224,613 | $-82,466 | $-80,875 |
| EPS Basic Total Ops | -0.74 | -0.46 | 1.59 | -0.58 | -0.57 |
| EPS Basic Continuous Ops | -0.74 | -0.46 | 1.59 | -0.58 | -0.57 |
| EPS Diluted Total Ops | -0.74 | -0.46 | 1.59 | -0.58 | -0.57 |
| EPS Diluted Continuous Ops | -0.74 | -0.46 | 1.59 | -0.58 | -0.57 |
| EBITDA(a) | $-75,391 | $-47,091 | $231,220 | $-75,058 | $-61,821 |